Difficulty: Medium
Average Score: 69%
Practice
Low molecular weight (LMW) heparins such as Enoxaparin, are derived from standard heparin through depolymerization. In contrast to unfractioned Heparin, what is the MOA of LMW heparins?
Correct answer
A
Rationale
The correct answer is A) LMW heparins and factor Xa inhibitors only inactivate factor Xa.
Low molecular weight (LMW) heparins, such as Enoxaparin, have a unique mechanism of action compared to unfractionated heparin. LMW heparins primarily work by inactivating factor Xa, which is a crucial component in the coagulation cascade. By inhibiting factor Xa, LMW heparins prevent the conversion of prothrombin to thrombin, thereby reducing the formation of blood clots.
Option B) stating that LMW heparins activate factor X is incorrect. LMW heparins do not activate factor X; instead, they inhibit factor Xa to prevent clot formation.
Option C) mentioning inactivation of factor XIa is also incorrect. LMW heparins primarily target factor Xa, not factor XIa.
Educationally, understanding the mechanism of action of LMW heparins is essential for healthcare professionals, especially in the context of managing thrombotic disorders. Knowing that LMW heparins specifically target factor Xa helps in making informed decisions regarding anticoagulant therapy and ensuring optimal patient care.
Low molecular weight (LMW) heparins, such as Enoxaparin, have a unique mechanism of action compared to unfractionated heparin. LMW heparins primarily work by inactivating factor Xa, which is a crucial component in the coagulation cascade. By inhibiting factor Xa, LMW heparins prevent the conversion of prothrombin to thrombin, thereby reducing the formation of blood clots.
Option B) stating that LMW heparins activate factor X is incorrect. LMW heparins do not activate factor X; instead, they inhibit factor Xa to prevent clot formation.
Option C) mentioning inactivation of factor XIa is also incorrect. LMW heparins primarily target factor Xa, not factor XIa.
Educationally, understanding the mechanism of action of LMW heparins is essential for healthcare professionals, especially in the context of managing thrombotic disorders. Knowing that LMW heparins specifically target factor Xa helps in making informed decisions regarding anticoagulant therapy and ensuring optimal patient care.